peter van der meer
Rijksuniversiteit Groningen
H-index: 89
Europe-Netherlands
Top articles of peter van der meer
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging | Annet Nicole Linders Itamar Braga Dias Teresa López Fernández Carlo Gabriele Tocchetti Nils Bomer | 2024/1/23 | |
Domestication of Euterpe oleracea (Arecaceae) to provide food from peatlands | IOP Conference Series: Earth and Environmental Science | HL Tata D Rachmanadi A Suwarno P van der Meer L Hein | 2024/3/1 |
Embedding routine health care data in clinical trials: with great power comes great responsibility | M Louis Handoko Frances S de Man Jasper J Brugts Peter van der Meer Hanneke FM Rhodius-Meester | 2024/1/15 | |
Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes | Redox Biology | Ali A Al-Mubarak George Markousis Mavrogenis Xuanxuan Guo Marco De Bruyn Mintu Nath | 2024/4/1 |
Disruption of TUFT1, a desmosome-associated protein, causes skin fragility, woolly hair, and palmoplantar keratoderma | Journal of Investigative Dermatology | Annemieke JMH Verkerk Daniela Andrei Mathilde CSC Vermeer Duco Kramer Marloes Schouten | 2024/2/1 |
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials | The Lancet | Javed Butler Sanjiv J Shah Mark C Petrie Barry A Borlaug Steen Z Abildstrøm | 2024/4/7 |
Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry | International Journal of Cardiology | Karen Sliwa Peter van der Meer Charle Viljoen Alice M Jackson Mark C Petrie | 2024/3/1 |
Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from … | European Journal of Heart Failure | Morten Schou Brian Claggett Zi Michael Miao Alberto Fernandez Gerasimos Filippatos | 2024/1 |
Urinary marker profiles in heart failure with reduced versus preserved ejection fraction | Journal of cardiovascular translational research | Koen W Streng Hans L Hillege Jozine M Ter Maaten Dirk J van Veldhuisen Kenneth Dickstein | 2024/2 |
Detection of cardiac amyloidosis on routine bone scintigraphy: an important gatekeeper role for the nuclear medicine physician | The International Journal of Cardiovascular Imaging | Mohit Nebhwani Karina Chaibekava Anouk Achten Marish IFJ Oerlemans Michelle Michels | 2024/3/23 |
Empagliflozin after acute myocardial infarction | New England Journal of Medicine | Javed Butler W Schuyler Jones Jacob A Udell Stefan D Anker Mark C Petrie | 2024/4/6 |
Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE‐HF | ESC heart failure | Pascal RD Clephas Jishnu Malgie Jeroen Schaap Stefan Koudstaal Mireille Emans | 2024/2 |
Primary Results From APOLLO-B Open-label Extension Study Of Patisiran In Patients With Transthyretin Cardiac Amyloidosis | Journal of Cardiac Failure | Mathew S Maurer John L Berk Mazen A Hanna Julian D Gillmore Pedro V Schwartzmann | 2024/1/1 |
High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients | Journal of Clinical Medicine | Hendrea SA Tingen Milou Berends Alwin Tubben Johan Bijzet Ewout J Houwerzijl | 2024/1/30 |
Angiotensin receptor-neprilysin inhibition in patients with STEMI vs NSTEMI | The Journal of Heart and Lung Transplantation | S Alishetti GM Mondellini L Braghieri A Javaid KL Antler | 2020/4/1 |
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial | Circulation | Adrian F Hernandez Jacob A Udell W Schuyler Jones Stefan D Anker Mark C Petrie | 2024/4/6 |
Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker? | European Journal of Nuclear Medicine and Molecular Imaging | HSA Tingen A Tubben J Bijzet MP van den Berg P van der Meer | 2024/2 |
Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM Registry | European Journal of Heart Failure | Alice M Jackson Johann Bauersachs Mark C Petrie Peter van der Meer Cecile Laroche | 2024/1 |
A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry | European Heart Journal | Alice M Jackson Sorel Goland Hasan Ali Farhan Israa Fadhil Yaseen Hawani Sasmaya Prameswari | 2024/1/29 |
Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study | European journal of heart failure | Alwin Tubben Hendrea SA Tingen Niek HJ Prakken Vanessa PM van Empel Thomas M Gorter | 2024/3/4 |
